eShowcase: ISI Solutions Platform
Regulatory solution suite from ISI migrates to new platform for improved integration
Regulatory solution suite from ISI migrates to new platform for improved integration
Image Solutions Inc. (Whippany, NJ) has migrated its regulatory product suite for the life sciences industry into the ISI Solutions Platform built on Microsoft's .NET Framework. By moving to the .NET Framework, companies will have one integrated platform from which to manage, review, and publish electronic submissions to the FDA.
The ISI Solutions Platform provides the technology foundation for the company's full suite of products. Its regulatory suite includes its flagship submission products, eCTDXPress and ISIPublisher. These products address the file preparation time in the submissions process. Additional productivity tools and templates are also included in the ISI Solutions Platform.
The .NET Framework gives the suite interoperability with other systems within and outside the company, including document management systems. It also features flexibility, solutions that can be easily scaled to the size of the organization, and common interfaces.
ISI, (973) 560-0404, www.imagesolutions.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
First Patient Dosed in Phase III Trial of Enhertu as First-Line Treatment for Endometrial Cancer
June 10th 2025In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 study for the treatment of patients with HER2-expressing, mismatch repair proficient primary advanced or recurrent endometrial cancer.
